INFLUENZA VACCINE COMMERCIALISATION
As an addition to an already globally recognised World Vaccine Congress series, World Influenza Congress Europe is positioned as Europe's largest and most influential Influenza vaccine COMMERCIALISATION event.
» request a sponsorship prospectus
2009 POST SHOW REPORT
Following the 2009 congress we have produced a post show report to give a brief overview of the event, the speakers, the attendees and what we have planned for 2010. It can be downloaded as a pdf.
» download the post show report
SPONSOR NOW FOR BEST RETURNS
The World Flu Congress Europe is where the World's pharmaceutical and biotech companies come to find solutions and ideas. If you are in the business of providing world-class solutions you need to be here.
-
The Congress is a marketing solution that generates new business
-
The Congress is attended by decision makers
-
The Congress is an unrivalled and cost-effective sales and profile solution
WHO SHOULD SPONSOR?
-
Contract Manufacture Organisations
-
Contract Research Organisations
-
Equipment Providers and Manufacturers
-
Delivery Technology Manufacturers
-
Vaccine Manufacturers and Biotechs
-
Vaccine Technology Platforms
-
Clinical Research Sites / Laboratories
-
Consultants
-
Law Firms
-
Venture Capital / Investment Banks
To discuss in detail your requirements and the show call Gaurav Koul on +44 (0) 207 092 1233 or email
gaurav.koul@terrapinn.com
meet new partners
1-2-1 PARTNERING
Opportunities with "Contact" - Schedule dedicated onsite meetings with partners and gain the visibility your company needs.
»
networking opportunities
designed for networking
KEY REASONS TO ATTEND
-
The World’s largest influenza and antivirals vaccine congress addressing global pandemic trends and key regulatory and industry response
-
Over 45 sessions covering strategic pandemic influenza preparedness and response with unique industry showcases
-
Unrivalled global participation from regulators, pharma and biotech with every key player in the influenza market participating